Skip to content

Clinical and Radiographic Evaluation of Laser Assisted Pulpotomy in Immature Permanent Molars With Symptoms Indicative of Irreversible Pulpitis

Clinical and Radiographic Evaluation of Laser Assisted Pulpotomy in Immature Permanent Molars With Symptoms Indicative of Irreversible Pulpitis (A Randomized Controlled Clinical Trial )

Status
Completed
Phases
Unknown
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT07704463
Enrollment
57
Registered
2026-07-15
Start date
2025-01-01
Completion date
2026-04-01
Last updated
2026-07-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Symptomatic Irreversible Pulpitis (SIP)

Brief summary

The goal of this clinical trial is to assess the clinical and radiographic success rate of Laser pulpotomy procedure done in immature permanent molars with symptoms indicative of irreversible pulpitis.. The main question it aims to answer is: whether the combined use of Laser pulpotomy with MTA capping material will provide faster healing with acceleration of complete root formation in immature permanent molars compared to MTA pulpotomy alone? Participants will: The coronal inflammed pulp will be carefully amputated to the level of the canal orifices. Hemostasis will be achieved by gentle placement of a saline-moistened cotton pellet and Placement of capping material will be performed in the study groups. The post-operative clinical follow up will be done after one week for patient reassurance. Then the postoperative clinical and radiographic follow-up will be scheduled up to twelve months.

Interventions

OTHERApplication of 660 nm diode laser

photobiomodulation (PBM) uses low-power irradiation from lasers or light-emitting diode (LED) devices to irradiate human tissues to stimulate dental pulp cells

OTHERApplication of 970 nm diode laser + MTA

Laser application with 970 nm wavelength to penetrate and affect pulpal cells

OTHERConventional MTA pulpotomy (control group)

The remaining pulp will be capped with MTA after final rinsing with saline

Sponsors

Alexandria University
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
SINGLE (Subject)

Eligibility

Sex/Gender
ALL
Age
6 Years to 14 Years
Healthy volunteers
No

Inclusion criteria

* Children with an age ranging between 6 to 14 years old with no gender predilection. * Children free of any systemic disease or special health care needs. * Patients complaining from intermittent or spontaneous, sharp, localized, diffuse, or referred pain. * Selected teeth should give long lasting positive responses to cold testing. * Soft tissues around the tooth are normal. * Periapical radiographs show deep carious lesions. * Patients with immature permanent molars (stages 8 and 9) according to Nolla's classification for tooth developmental stage. * Periapical index score 1 or 2. * Following pulpal amputation, hemostasis could be easily achievable within 5 to 10 minutes with a sterile moist cotton pellet.

Exclusion criteria

* Child with bad experience of dental treatment (uncooperative patient). * Non-restorable teeth. * Negative response to cold testing. * Bleeding could not be controlled. * Absence of bleeding from any of the canals. * Pus discharge through an associated sinus tract. * Pulpal calcifications * Radiographic signs of internal or external resorption.

Design outcomes

Primary

MeasureTime frame
to assess the clinical and radiographic success rate of Laser pulpotomy procedure done in immature permanent molars with symptoms indicative of irreversible pulpitis.12 months

Secondary

MeasureTime frame
1. Evaluation of laser effect on decreasing immediate postoperative pain using Numerical Rating Pain Scale with min (0) No pain - max (10) severe pain. 2. Evaluation of laser effect on dentin bridge formation (if it is radiographically present or not).12 months

Countries

Egypt

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Jul 16, 2026